Aditum Bio
Josh Gertsman is a finance professional with extensive experience in investment banking and mergers & acquisitions. Currently a Partner at Aditum Bio, Josh has also held the positions of Principal and Senior Associate. Before this, Josh worked at Dyal Co. LLC as an M&A Investment Banking Associate and Analyst, and at BMO Capital Markets as an Analyst in Mergers & Acquisitions. Josh holds a Master of Business Administration (MBA) in Health Care Management from The Wharton School and a Bachelor of Commerce (B.Com.) in Finance and Accounting from Carleton University.
This person is not in the org chart
This person is not in any teams
Aditum Bio
Aditum Bio is an investment fund that specializes in acquiring and developing pharmaceutical assets. It gives patients access to medicines that may not otherwise be developed. Aditum Bio was founded on 2019 and is headquartered in San Francisco, California.